LQDA
Liquidia Corporation Common Stock
Nasdaq · usd
Liquidia Corporation Common Stock (LQDA) trades at $44.34 (+3.97%) as of 2:24:12 PM EDT on Oct 26, 2026, -35.17% over the past month. Market cap is $3.82B, with 3.8 days to cover in short interest.
Stock performance
How Liquidia Corporation Common Stock (LQDA) stock has performed from one day to one year, with its 52-week range.
- 1D
- +4.01%
- 1W
- +29.97%
- 1M
- -35.17%
- YTD
- +28.62%
- 1Y
- +94.90%
- 52-wk range
- $22.05 – $93.61
Key statistics
Today's trading snapshot for LQDA: day range, open, previous close, volume and market cap.
- Day range
- $42.12 – $45.72
- Open
- $42.77
- Prev close
- $42.65
- Volume
- 2.8M
- Market cap
- $3.82B
- Shares out
- 89.51M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Liquidia Corporation Common Stock: P/E, P/S, P/B, ROE and more.
- P/E
- 27.54
- P/S
- 8.47
- P/B
- 19.57
- P/FCF
- 25.33
- ROE
- 71.0%
- ROA
- 26.6%
- Debt/Equity
- 0.90
- Div yield
- 0.00%
As of Oct 23, 2026
8-K filings
Material corporate events Liquidia Corporation Common Stock has disclosed to the SEC on Form 8-K.
- Settlement agreementOct 14, 2026
On October 11, 2026, the Company entered into a Settlement and Termination Agreement with Sandoz ... to settle Sandoz's entitlement to a fifty percent (50%) share of the proceeds from the RareGen Litigation.
- Regulatory decisionSep 3, 2026
On September 3, 2026, Liquidia Corporation ... issued a press release announcing that the U.S. Food and Drug Administration has granted Fast Track Designation to YUTREPIA® (treprostinil) inhalation powder for the treatment of Raynaud's phenomenon associated with systemic sclerosis.
- Investor presentationAug 12, 2026
On August 12, 2026, the Company updated its corporate presentation that it uses for presentations at healthcare conferences and to analysts, current stockholders, and others.
- Annual meeting resultsJun 17, 2026
At the Annual Meeting, the three Class II directors were elected, the appointment of the Company's independent registered public accounting firm for the year ending December 31, 2026 was ratified and the compensation of the NEOs was approved by non-binding advisory vote.
- Investor presentationMay 11, 2026
On May 11, 2026, the Company updated its corporate presentation that it uses for presentations at healthcare conferences and to analysts, current stockholders, and others.
LQDA short interest
How heavily LQDA is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 3.8
- Short interest
- 12.64M
- Avg volume
- 3.29M
As of · reported to FINRA twice monthly.
LQDA news
The latest news and headlines about Liquidia Corporation Common Stock (LQDA).
- Liquidia Corporation (LQDA) Earnings Expected to Grow: Should You Buy?negativeZacks Investment Research· Oct 26, 2026
- LQDA Settles UTHR Disputes for $380.7M, Limits Yutrepia LabelnegativeZacks Investment Research· Oct 14, 2026
- LIQUIDIA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Liquidia Corporation on Behalf of Liquidia Stockholders and Encourages Investors to Contact the FirmnegativeGlobeNewswire Inc.· Oct 7, 2026
- Liquidia Stock Plunges 57% on UTHR Patent Litigation SetbacknegativeZacks Investment Research· Oct 1, 2026
- UTHR Prevails in LQDA's Yutrepia Patent Dispute, Stock Up Nearly 13%positiveZacks Investment Research· Oct 1, 2026
Frequently asked questions
What is the Liquidia Corporation Common Stock (LQDA) stock price today?
Liquidia Corporation Common Stock (LQDA) is trading at $44.34 (+3.97% on the day) as of 2:24:12 PM EDT on Oct 26, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Liquidia Corporation Common Stock?
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary…
What is the short interest in LQDA?
As of Sep 30, 2026, LQDA has 12.64M shares short and 3.8 days to cover.
What exchange is LQDA listed on?
Liquidia Corporation Common Stock (LQDA) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.
Build with AI
Build an analysis of LQDA with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a LQDA analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.